MediciNova
Price & Volume
Stats
See more52W Range | $1.13-$2.06 |
Market Cap | $70.7M |
Shares Short | 281,668 |
Financials
See moreRevenue (12 Mos) | $257,918 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $26,297 |
Diluted EPS | -$0.25 |
News
See moreYahoo Finance • 29 days ago
MediciNova Announces Completion of Patient Enrollment Evaluating MN-166 (ibudilast) in the Prevention of Chemotherapy-induced Peripheral Neuropathy
Yahoo Finance • last month
MediciNova Announces Update and Basic Characteristic Randomized Patients’ of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND
Yahoo Finance • 2 months ago
MediciNova Appoints Dr. Christopher Breder, MD, PhD as Clinical and Regulatory Advisor
Yahoo Finance • 2 months ago
MediciNova Wins Contract Research and Development Innovation Award at 2025 BioTech Breakthrough Awards
About
CEO | Dr. Yuichi Iwaki M.D., Ph.D. |
CFO | Mr. Jason J. Kruger CPA |
Address | 4275 Executive Square, La Jolla, CA, United States, 92037 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 13 |
